세계의 m-RNA 합성 서비스 시장 보고서(2025년)
m-RNA Synthesis Service Global Market Report 2025
상품코드 : 1769664
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,471,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,354,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,236,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

m-RNA 합성 서비스 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 이러한 성장은 m-RNA 치료법의 사용 증가, m-RNA 기술의 폭넓은 적용, 자가 면역 질환에 대한 m-RNA 치료에 대한 관심 증가, m-RNA 기반 백신의 지속적인 수요, 맞춤형 m-RNA 합성 솔루션에 대한 필요성 증가에 기인합니다. 이 기간 동안 예상되는 주목할 만한 동향으로는 RNA 중합 효소 공학의 혁신, 차세대 m-RNA 백신의 개발, m-RNA 제조의 자동화, 맞춤형 m-RNA 치료제, m-RNA 설계에 AI 및 머신 러닝의 통합 등이 있습니다.

맞춤형 의약품에 대한 관심이 높아짐에 따라 m-RNA 합성 서비스 시장은 앞으로 더욱 성장할 것으로 예상됩니다. 맞춤형 의약품은 개인의 유전적 구성, 생활 방식 및 환경에 맞게 치료 및 의료 결정을 맞춤화하는 의료 접근 방식을 의미합니다. 이 접근 방식은 질병 및 치료 반응과 관련된 개인의 유전적 변이를 보다 정확하게 식별할 수 있게 하는 게놈 시퀀싱의 발전으로 인해 추진력을 얻고 있습니다. m-RNA 합성 서비스는 개인의 유전적 프로필에 맞춤화된 m-RNA 기반 치료법을 신속하고 정확하게 생산할 수 있게 함으로써 맞춤형 의약품에 대한 강조가 높아지는 것을 지원하여, 보다 효과적이고 표적화된 치료를 가능하게 합니다. 예를 들어, 2024년 2월, 미국에 본사를 둔 비영리 단체인 Personalized Medicine Coalition은 FDA가 2023년에 희귀 질환 환자를 위한 16개의 새로운 맞춤형 치료법을 승인했다고 밝혔습니다. 이 중 7개는 암 치료제이고, 3개는 다른 질병 및 증상을 치료하는 약품입니다. 이처럼 맞춤형 의약품에 대한 관심이 높아짐에 따라 m-RNA 합성 서비스 시장도 확대되고 있습니다.

m-RNA 합성 서비스 시장에서 활동하는 주요 기업들은 m-RNA 합성의 효율성, 수율 및 안전성을 개선하기 위해 RNA 중합 효소 혁신과 같은 혁신적인 솔루션을 개발하는 데 주력하고 있습니다. RNA 중합 효소 혁신은 전사 과정을 강화하고, 이중 가닥 RNA 형성 같은 부작용을 줄이며, 백신 및 치료제에 사용되는 m-RNA의 전반적인 품질을 개선하는 첨단 효소의 개발을 포함합니다. 예를 들어, 2025년 3월, 미국에 본사를 둔 생명공학 기업인 Primrose Bio Inc.는 m-RNA 합성의 효율성과 확장성을 높이기 위해 Prima RNApols를 출시했습니다. 이 효소는 향상된 처리 능력과 고성능 전사를 제공하여 오류율이 더 낮고 더 길고 안정적인 m-RNA 가닥을 생산할 수 있게 합니다. 이 효소는 체외 전사 시스템에서 강력한 성능을 발휘하여 불순물을 최소화하고 수율을 높임으로써 m-RNA 기반 의약품을 개발하는 기업에 신뢰할 수 있고 확장 가능한 솔루션을 제공합니다. 이 혁신은 정확하고 효율적인 m-RNA 합성이 중요한 맞춤형 의약품 분야에서 특히 중요합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별, 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

A messenger ribonucleic acid (mRNA) synthesis service involves the production of custom mRNA molecules through in vitro transcription using a provided deoxyribonucleic acid (DNA) template. These services are utilized for various purposes, including vaccine development, gene therapy, and research in protein expression and functional genomics.

The primary types of mRNA synthesis services include mRNA vaccine synthesis and mRNA drug synthesis. mRNA vaccine synthesis refers to the laboratory process of generating mRNA sequences that guide cells to produce a specific protein, which triggers an immune response to combat infectious diseases. These services support several application areas such as vaccine development, therapeutic development, research and development, and diagnostics. The end-users of these services include pharmaceutical companies, biotechnology firms, academic and research institutions, and contract research organizations (CROs).

The mRNA synthesis service market research report is one of a series of new reports from The Business Research Company that provides mRNA synthesis service market statistics, including the mRNA synthesis service industry global market size, regional shares, competitors with the mRNA synthesis service market share, detailed mRNA synthesis service market segments, market trends, and opportunities, and any further data you may need to thrive in the mRNA synthesis service industry. This mRNA synthesis service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The mRNA synthesis service market size has grown strongly in recent years. It will grow from $4.54 billion in 2024 to $4.99 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. Growth during this historical period was driven by the rising demand for personalized medicine and gene therapies, the expansion of clinical trials, increased prevalence of infectious diseases, heightened investment in biotechnology, and an intensified focus on vaccine development.

The mRNA synthesis service market size is expected to see strong growth in the next few years. It will grow to $7.22 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. This anticipated growth is attributed to the increasing use of mRNA therapies, broader applications of mRNA technology, heightened focus on mRNA treatments for autoimmune diseases, sustained demand for mRNA-based vaccines, and rising need for custom mRNA synthesis solutions. Notable trends expected during this period include innovations in RNA polymerase enzyme engineering, development of next-generation mRNA vaccines, automation in mRNA manufacturing, personalized mRNA therapeutics, and the integration of AI and machine learning in mRNA design.

The increasing focus on personalized medicine is expected to propel the growth of the mRNA synthesis service market going forward. Personalized medicine refers to a medical approach that tailors treatment and healthcare decisions to an individual's genetic makeup, lifestyle, and environment. This approach is gaining momentum due to advancements in genomic sequencing, which allow for more precise identification of individual genetic variations linked to disease and treatment response. mRNA synthesis services support the growing emphasis on personalized medicine by enabling the rapid and precise production of mRNA-based therapies tailored to an individual's genetic profile, resulting in more effective and targeted treatments. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized treatments in 2023 for patients with rare diseases, up from 6 in 2022. Among these, seven were cancer drugs, and three addressed other diseases and conditions. As such, the increasing focus on personalized medicine is driving the expansion of the mRNA synthesis service market.

Major companies operating in the mRNA synthesis service market are focusing on developing innovative solutions, such as RNA polymerase innovations, to improve the efficiency, yield, and safety of mRNA synthesis. RNA polymerase innovations involve the development of advanced enzymes that enhance the transcription process, reduce side effects like double-stranded RNA formation, and improve the overall quality of mRNA used in vaccines and therapeutics. For instance, in March 2025, Primrose Bio Inc., a US-based biotechnology company, introduced Prima RNApols to enhance the efficiency and scalability of mRNA synthesis. This enzyme offers enhanced processivity and high-fidelity transcription, enabling the production of longer and more stable mRNA strands with lower error rates. Its robust performance in in vitro transcription systems minimizes impurities and increases yield, providing a reliable and scalable solution for companies developing mRNA-based drugs. This innovation holds particular significance in personalized medicine, where accurate and efficient mRNA synthesis is critical.

In December 2024, Novo Holdings A/S, a Denmark-based investment firm, acquired Catalent Inc. for $16.5 billion. This acquisition is aimed at strengthening Novo Holdings' position in the life sciences sector by boosting its capabilities in drug development and supply while promoting sustainable value creation through an engaged ownership model. Catalent Inc., a US-based company, specializes in mRNA synthesis services for therapeutics and vaccines.

Major players in the m-rna synthesis service market are Thermo Fisher Scientific Inc., Danaher Corporation, AGC Biologics Inc., Eurofins Scientific SE, Lonza Group AG, Catalent Inc., Samsung Biologics Co. Ltd., WuXi Biologics (Cayman) Inc., GenScript Biotech Corporation, Azenta Inc., Genewiz Inc., New England Biolabs Inc., TransGen Biotech Co. Ltd., Creative Biolabs Inc., Bioneer Corporation, Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC, and APExBIO Technology LLC.

North America was the largest region in the m-RNA synthesis service market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in mRNA synthesis service report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the mRNA synthesis service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mRNA synthesis service market consists of revenues earned by entities by providing services such as template DNA preparation, codon optimization, stability and storage testing, and regulatory support for clinical applications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

m-RNA Synthesis Service Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on m-rna synthesis service market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for m-rna synthesis service ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The m-rna synthesis service market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. m-RNA Synthesis Service Market Characteristics

3. m-RNA Synthesis Service Market Trends And Strategies

4. m-RNA Synthesis Service Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global m-RNA Synthesis Service Growth Analysis And Strategic Analysis Framework

6. m-RNA Synthesis Service Market Segmentation

7. m-RNA Synthesis Service Market Regional And Country Analysis

8. Asia-Pacific m-RNA Synthesis Service Market

9. China m-RNA Synthesis Service Market

10. India m-RNA Synthesis Service Market

11. Japan m-RNA Synthesis Service Market

12. Australia m-RNA Synthesis Service Market

13. Indonesia m-RNA Synthesis Service Market

14. South Korea m-RNA Synthesis Service Market

15. Western Europe m-RNA Synthesis Service Market

16. UK m-RNA Synthesis Service Market

17. Germany m-RNA Synthesis Service Market

18. France m-RNA Synthesis Service Market

19. Italy m-RNA Synthesis Service Market

20. Spain m-RNA Synthesis Service Market

21. Eastern Europe m-RNA Synthesis Service Market

22. Russia m-RNA Synthesis Service Market

23. North America m-RNA Synthesis Service Market

24. USA m-RNA Synthesis Service Market

25. Canada m-RNA Synthesis Service Market

26. South America m-RNA Synthesis Service Market

27. Brazil m-RNA Synthesis Service Market

28. Middle East m-RNA Synthesis Service Market

29. Africa m-RNA Synthesis Service Market

30. m-RNA Synthesis Service Market Competitive Landscape And Company Profiles

31. m-RNA Synthesis Service Market Other Major And Innovative Companies

32. Global m-RNA Synthesis Service Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The m-RNA Synthesis Service Market

34. Recent Developments In The m-RNA Synthesis Service Market

35. m-RNA Synthesis Service Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기